Search
Now showing items 1-2 of 2
Article
In vitro antiviral activity of the anti-HCV drugs daclatasvir and sofosbuvir against SARS-CoV-2, the aetiological agent of COVID-19
| Date Issued:
2021 | Copyright:
open access
Article
The clinically approved antiviral drug sofosbuvir inhibits Zika virus replication
| Date Issued:
2017 | Copyright:
open access